Skip to main content
Premium Trial:

Request an Annual Quote

European Commission Provides VIB $4.3M for New Researchers

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Belgian life science research institute VIB today announced it is receiving €3 million ($4.3 million) to recruit and train scientists in integrative biology.

The funding comes from the European Commission's Mari Curie FP7 Cofund program, and will further introduce the newest high-throughput technologies within the non-profit institute, it said.

A condition of the funding is the expansion of integrative biology, which combines different technologies and disciplines, within VIB, with an emphasis on 'omics technologies.

"The people, technology, and knowledge that we can acquire thanks to the European Commission will make it possible to enhance the role of Flanders as a cutting-edge biotech region," Jo Bury, a managing director at VIB, said in a statement.

New researchers recruited by VIB will have 40 percent of their salaries paid by the EC, and VIB will pay the remaining 60 percent.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.